0001594062-19-000074.txt : 20190918 0001594062-19-000074.hdr.sgml : 20190918 20190819200010 ACCESSION NUMBER: 0001594062-19-000074 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JUVA LIFE INC./Canada CENTRAL INDEX KEY: 0001778651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1500 - 885 WEST GEORGIA ST CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 16048627953 MAIL ADDRESS: STREET 1: 1500 - 885 WEST GEORGIA ST CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 CORRESP 1 filename1.htm
 
 
August 19, 2019
 
VIA EDGAR
 
Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549
 
Attention:   Jeffrey Gabor
      Mary Beth Breslin
 

Re:           Juva Life Inc./Canada
                 Offering Statement on Form 1-A
                 File No. 024-11014
 
 
Dear Mr. Gabor and Ms. Breslin:
 
Juva Life Inc., a British Columbia corporation, hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Offering Statement to become qualified at 4:00 PM Eastern Time on August 20, 2019, or as soon thereafter as possible.
 
Should you have any questions or require any additional information with respect to this filing, please contact Rebecca DiStefano at (561) 955-7654. Thank you for your assistance and cooperation.
 
Very truly yours,


JUVA LIFE INC.
 
By: /s/ Douglas Chloupek
Name: Douglas Chloupek
Title: Chief Executive Officer